Form 8-K - Current report:
SEC Accession No. 0001213900-20-039814
Filing Date
2020-11-30
Accepted
2020-11-30 09:26:19
Documents
2
Period of Report
2020-11-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea130705-8k_wizepharma.htm 8-K 32030
2 ADDENDUM AGREEMENT, BETWEEN WIZE PHARMA, INC. AND BONUS BIOGROUP LTD., DATED NOV ea130705ex10-1_wizepharma.htm EX-10.1 56434
  Complete submission text file 0001213900-20-039814.txt   89747
Mailing Address 24 HANAGAR ST HOD HASHARON L3 4527713
Business Address 24 HANAGAR ST HOD HASHARON L3 4527713 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

EIN.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52545 | Film No.: 201356562
SIC: 2834 Pharmaceutical Preparations